Âé¶¹ÃÛÌÒmvÔÚÏß¹Û¿´

Âé¶¹ÃÛÌÒmvÔÚÏß¹Û¿´
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

SPONSORED BY
Related news about the opioid crisis and improving patient outcomes
Legislators look at the limited ways opioid settlement funds can be spent across the state
Seattle Fire Department medics responded to 253 overdoses in June 2024 compared to 386 in 2023
Plum EMS is working to get overdose patients who refuse transport to the hospital into treatment programs
An initial visual assessment can identify threats to you and your patient before you narrow down a differential diagnosis
The Independence Day holiday can increase the number of intoxicated patients and bystanders you’re likely to encounter on your shift so be careful out there
How communities are saving lives by understanding where and when overdoses occur
For both intubated and non-intubated patients, capnography can provide a wealth of information about vital signs
Waveform capnography provides real-time feedback that BLS providers can use to make treatment decisions and improve care
The use of waveform capnography as a monitoring and diagnostic tool extends far beyond airway management and cardiac arrest
Going back to the basics ensures a smooth EtCO2 reading and creates a calming environment for both the patient and provider
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.